Results of a pharmacoeconomic analysis of the rationality of the use of acute myeloid leukemia chemotherapy regimens with the use of various doses of cytarabine
Panfilova, H.,
Goncharova, A.,
Korzh, I.,
Zhirova, I.,
Tsurikova, O.,
Bezuglaia, N.
Связанные документы (рекомендация CORE)